Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.
Terry L NgYiwei LiuAnastasios DimouTejas PatilDara L AisnerZhengwei DongTao JiangChunxia SuChunyan WuShengxiang RenCaicun ZhouD Ross CamidgePublished in: Cancer (2018)
Among associated clinical features among patients who have NSCLC with oncogenic drivers, smoking status potentially was the most important, easily available predictor of single PDi efficacy.